Because ipamorelin works on a different receptor than the GHRH peptides, it is most often used in combination with one of them rather than alone
Although more data is needed from RCTs and there are indeed cost challenges, the GLP-1RAs have, in my opinion, significant potential clinical implications in treatment of other disease states as well
However, these medications also face several challenges, including low stability in the body, short half-lives, poor membrane permeability, complex manufacturing processes, and high costs
In animal studies, Dihexa was found to be approximately 1,000 times more potent than BDNF (brain-derived neurotrophic factor) at promoting synapse formation
Long-acting release formulation of exendin-4 based on biomimetic mineralization for type 2 diabetes therapy